The new challenges for chemotherapy research

Leprosy Review

Volumn 71, Issue SUPPL., 2000, Pages

  Grosset, J ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LEPROSTATIC AGENT;

CONFERENCE PAPER; DRUG RESEARCH; HUMAN; INFECTION CONTROL; LEPROSY; MEDICAL RESEARCH; WORLD HEALTH ORGANIZATION;

EID: 0034491976     PISSN: 03057518     EISSN: None     Source Type: Journal    
DOI: 10.5935/0305-7518.20000078     Document Type: Conference Paper

References (12)

1. Progress towards the elimination of leprosy as a public health problem
2. Activity of minocycline in Mycobacterium leprae-infected mice
3. Bactericidal activities of combinations of new drugs against Mycobacterium leprae in nude mice
4. Recent advances in the chemotherapy of leprosy
5. Bactericidal activities of single or multiple doses of various combinations of new antileprosy drugs and/or rifampin against M. leprae in mice
6. Bactericidal activities of HMR 3647, moxifloxacin and rifapentine against Mycobacterium leprae in mice
7. Bactericidal activity of a single dose of clarithromycin plus minocycline, with or without ofloxacin, against Mycobacterium leprae in patients
8. Multidrug resistance to dapsone, rifampicin, and ofloxacin in Mycobacterium leprae